Empagliflozin and pirfenidone confer renoprotection through suppression of glycogen synthase kinase-3β and promotion of tubular regeneration in rats with induced metabolic syndrome
Article in Toxicology and Applied Pharmacology (March 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Toxicology and Applied Pharmacology (March 2024)
Article in Molecular Medicine Reports (March 2024)
Article in Expert Opinion on Investigational Drugs (March 2024)